´ÔÀº
ÀÔ´Ï´Ù.
¤ýÃѱ¸¸Å¾×
0
¿ø
¤ýÀû¸³±Ý
0
¿ø
¤ýÇÒÀÎÄíÆù
0
¿ø
¤ýÀå¹Ù±¸´Ï
0
°³
¤ýÀ§½Ã¸®½ºÆ®
0
°³
test
Log-in
Register
Shopping Cart
My Account
Practitioner code is required for product purchase.
About Us
Motto of MetaFormula
Doctor¡¯s Health Recipe
MF News
Supplements
reTG Omega3
Vitamin D3
Pluseed¢â
ARG Formula
Beau'Clean¢â
NK365¢â
Jarrow Fem Dophilus
Ca.Mg.Vitamin D
Circulation Formula
CoEQ10 Formula
Energy Formula
Eye Care Formula
Folic acid &
Vitamin B6, B12
Hepa Formula
Joint Formula
Vitamin D3 1000
Optimal Mg
Optimal Zinc
Probio 500
Relax Formula
reTG Omega-3
Urinary Tract Formula
V Plus
Cosmetics
Natural ProCream 3 oz.
Vitamins
Vitamin A
Vitamin B1
Vitamin B2
Niacin (B3)
Pantothenic Acid (B5)
Vitamin B6
Folic Acid (B9)
Vitamin B12
Vitamin C
Vitamin D
VitaminE
Minerals
Zinc
Magnesium
Calcium
Selenium
Natural Herbs
Ginko Biloba
Hawthone
St. John¡¯s wort
Cranberry
Passion flower
Rosehip
Lutein
Milk Thistle
Boswellia
Billberry
Psyllium Husk
Shitake Mushroom
Oriental Rasin Tree
Valerian
Velvet Bean
Astazanthin
Amino Acids
Amino acids
L-Arginine
Taurine
L-Theanine
Others
Omega-3
Coenzyme Q10
N-acetylglucosamine
MSM
GABA
Inositol
Probiotics
Phosphatidylserine
Practitioner Registration
Practitioner Online order
Product References
Library
Share Tips
Gold Zone
Need Help?
How to Purchase
FAQs
Our Source
Vitamin
Mineral
Natural Herbs
Amino Acids
Others
<p align="center"><font color="#2080d0" face="Arial" size="6"><strong><br></strong></font></p><p align="center"><font color="#2080d0" size="6"><strong><br><font face="Tahoma"></font></strong></font></p><p align="center"><font color="#2080d0" face="Tahoma" size="6"><strong>Coenzyme Q10</strong></font></p><font face="Tahoma"> </font><p><br></p><p><br></p><p><font face="Tahoma"><br></font></p><font face="Tahoma"><p><br></p><p><br></p></font><p><font face="Tahoma" size="3"> <br></font></p><p style="margin: 1.5pt 0cm;"><strong><span lang="EN-US" style="color: rgb(32, 128, 208); font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="4">What is Coenzyme Q10?</font></span></strong></p><p><font face="Tahoma" size="3"> <br></font></p><p style="margin-top: 1.5pt;"><font face="Tahoma"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;">Also known as </span><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;">¡®ubiquinone¡¯, Coenzyme Q10 is not categorized as vitamin group because it is subject to biosynthesis in the human body. Instead, Coenzyme Q10 is categorized as ¡®vitamin-alike activity factor¡¯ as it has similar effects to vitamin. In addition, when taken in fat-soluble vitamin, it needs fat for intestinal absorption, Without fat, it will be only discharged from the body.</span></font></p><p><font face="Tahoma"> <br></font></p><p style="margin-top: 1.5pt;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Coenzyme Q10 exists in all cells in our body, but its concentration varies depending on tissues. In many cases, respiratory activity is mainly found in heart, liver, kidney, pancreas and gum, which means Coenzyme Q10 is very important nutrient to maintain vital activity.</font></span></p><p><font face="Tahoma"> <br></font></p><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Meanwhile, Coenzyme Q10 decreases together with the slow reduction in production capability during one¡¯s 20s, which leads to gradual aging due to weakened cell functions and the failure of rapid generation. Therefore, this component needs to be taken for supplement.</font></span></p><p><font face="Tahoma"> <br></font></p><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Nutrients helpful for Coenzyme Q10 production in the human body, includes vitamin E, vitamin B2, niacin, vitamin B6, vitamin B12, taurine, folic acid, vitamin C and selenium.</font></span></p><p><font face="Tahoma"> <br></font></p><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: black; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"> </font></span></p><p><font face="Tahoma" size="3"> <br></font></p><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò; mso-no-proof: yes;"><font face="Tahoma" size="3"><img onLoad='miniSelfResize(contents_44,this); if(this.parentNode.tagName=="A"){this.onclick = "";}' width="683" height="320" alt="http://metaformula.co.kr/shop/data/editor/1395213639.jpg" src="data:image/png;base64,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" v:shapes="±×¸²_x0020_2"></font></span></p><p><font face="Tahoma" size="3"> <br></font></p><p style="margin: 1.5pt 0cm;"><b><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"> </font></span></b></p><p><font face="Tahoma" size="3"> <br></font></p><font face="Tahoma"><font size="3"> </font><font size="3"> </font><font size="3"> </font><font size="3"> </font></font><table style="margin: auto auto auto 5.4pt; border: currentColor; border-image: none; border-collapse: collapse; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;" border="1" cellspacing="0" cellpadding="0"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;"><td width="680" valign="top" style="padding: 0cm 5.4pt; border: 1pt solid windowtext; border-image: none; width: 18cm; background-color: transparent; mso-border-alt: solid windowtext .5pt;"><font face="Tahoma" size="3"> </font><p style="margin: 1.5pt 0cm;"><b><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"> </font></span></b></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><font face="Tahoma"><b><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;">Biodistribution of </span></b><b><span lang="EN-US" style="color: rgb(146, 208, 80); mso-fareast-font-family: µ¸¿ò;">Coenzyme Q10</span></b></font></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">The concentration of Coenzyme Q10 is reduced in the body, with advancing years, which indicates that it is closely related to oxidation of cells. </font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"> </font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Liver</font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Lung</font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Kidney</font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">Heart</font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma">20s<span style="mso-tab-count: 1;"> </span>40s<span style="mso-tab-count: 1;"> </span>60s<span style="mso-tab-count: 1;"> </span>80s</font></span></p><font face="Tahoma"> </font><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"> </font></span></p><font face="Tahoma" size="3"> </font></td></tr></tbody></table><p><font face="Tahoma" size="3"> <br></font></p><p style="margin: 1.5pt 0cm;"><font face="Tahoma"></font></p><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><p style="margin: 1.5pt 0cm;"><font face="Tahoma"></font></p><font face="Arial"><p style="margin: 1.5pt 0cm;"><font face="Tahoma"> <font color="#000000" size="3"> </font></font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: rgb(32, 128, 208); font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="4">Effect of Coenzyme Q10</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="3"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"> </font></span><strong><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">1. Antioxidant effect</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> With its antioxidant effect, Coenzyme Q10 removes active oxygen that damages cells, thereby helping maintain health in daily life for long time. Attacked by active oxygen, cells lose functions or become changed in nature. Coenzyme Q10 is effective to eliminate active oxygen, thereby helping health physical functions.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> </font></span><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">2. Energy generation and fatigue recovery</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> Coenzyme Q10 is the essential coenzymes that make the energy source named ATP through fatty acid metabolism in cellular mitochondria. 95% of energy necessary for human body is made through this path, to help recharge vitality.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000" face="Tahoma" size="2"> </font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">3. Reducing blood pressure</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> When Coenzyme Q10 taken, hypertensive patients showed the reducing blood pressure both during contraction period and relaxation period.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> </font></span><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">4. Sperm activity</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> Low concentration in Coenzyme Q10 and phospholipid of sperms can cause asthenospermia and sterility. In the results of having a male sterile take 200mg of Coenzyme Q10 (twice a day) for 6 months, there was the increase in both sperm motility and pregnancy rate.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> </font></span><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">5. Strengthened immunity</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> Coenzyme Q10 is effective as a supplement for cancer prevention and AIDs cure purposes.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> </font></span><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">6. Improved periodontitis</font></span></strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> Lack of Coenzyme Q10 leads to no metabolism of citric acid but accumulated in gum, causing infection. Coenzyme Q10 reduces gum blooding and infection.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> </font></span><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">7. Anti-aging of skin</font></span></strong><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma" size="2"> Coenzyme Q10 has the effects to strengthen the generation of skin cells and elasticity as well as to remove wrinkles. Also, it has whitening effect, by inhibiting melanin.</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="3"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000" face="Tahoma" size="3"> </font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="3"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000" face="Tahoma" size="3"> </font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="3"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: rgb(32, 128, 208); font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="4">Related Articles</font></span></strong></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: rgb(32, 128, 208); font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma"><br></font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="3"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: gray; font-size: 11pt; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">1. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. (Langsjoen H1, Langsjoen P, Langsjoen P, Willis R, Folkers K. Mol Aspects Med. 1994;15 Suppl:s165-75.)</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: Coenzyme Q10 is a supplement safe and effective to cardiovascular disorders.</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"><font size="2"><font color="#000000"> </font><span style="color: gray;">2. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. (Singh RB1, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. J Hum Hypertens. 1999 Mar;13(3):203-8.)</span></font></font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: Coenzyme Q10 reduces oxidation stress, thereby lowering blood pressure.</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000" face="Tahoma" size="2"> </font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">3. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. (Beal MF. Biofactors. 1999;9(2-4):261-6.)</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><font face="Tahoma"><font size="2"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;">: The intake of Coenzyme Q10 reduces the concentration of high lactic acid of patients with Huntington's chorea (a rare disease common during one¡¯s 30s), which can be used as a medicine for neurodegenerative diseases.</span></strong><b><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000"> </font></span></b></font></font></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><font color="#000000" face="Tahoma" size="2"> </font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">4. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. (Singh RB1, Neki NS, Kartikey K, Pella D, Kumar A, Niaz MA, Thakur AS. Mol Cell Biochem. 2003 Apr;246(1-2):75-82.)</font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: Coenzyme Q10 has beneficial effects on myocardial infarction patients which belong to high-risk group thrombosis patient category.</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"><font size="2"><font color="#000000"> </font><span style="color: gray;">5. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. (Safarinejad MR. J Urol. 2009 Jul;182(1):237-48. doi: 10.1016/j.juro.2009.02.121. Epub 2009 May 17.)</span></font></font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: There was efficacy of Coenzyme Q10 supplement on semen parameters.</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"><font size="2"><font color="#000000"> </font><span style="color: gray;">6. Effects of L-Carnitine and Coenzyme Q10 on Impaired Spermatogenesis Caused by Isoproterenol in Male Rats. (Ghanbarzadeh S1, Garjani A, Ziaee M, Khorrami A. Drug Res (Stuttg). 2013 Nov 27. [Epub ahead of print])</span></font></font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: The intake of L-Carnitine and Coenzyme Q10 improved semen parameters impaired by Isoproterenol (ISO).</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"><font size="2"><font color="#000000"> </font><span style="color: gray;">7. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. (Kumar A1, Kaur H. Pharmacol Ther. 2009 Dec;124(3):259-68. doi: 10.1016/j.pharmthera.2009.07.003. Epub 2009 Jul 25.)</span></font></font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><span lang="EN-US" style="mso-fareast-font-family: µ¸¿ò;"><br><font face="Tahoma"><font size="2"><font color="#000000"> </font><span style="color: gray;">8. Coenzyme Q10 and cognition in atorvastatin treated dogs. (Martin SB1, Cenini G, Barone E, Dowling AL, Mancuso C. 2011 Aug 26;501(2):92-5. doi: 10.1016/j.neulet.2011.06.054. Epub 2011 Jul 8.)</span></font></font></span></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p><p style="margin: 6pt 0cm 0pt;"><strong><span lang="EN-US" style="color: gray; mso-fareast-font-family: µ¸¿ò;"><font face="Tahoma" size="2">: The concentration of Coenzyme Q10 in brain is related to improving impaired cognition, in atorvastatin treatment.</font></span></strong></p><p style="margin: 1.5pt 0cm;"><font color="#000000" face="Tahoma" size="2"> </font></p></font><p style="margin: 1.5pt 0cm;"></p></span><p style="margin: 1.5pt 0cm;"></p><p><font face="Arial" size="3"> <br></font></p><p style="margin: 1.5pt 0cm;"><span lang="EN-US" style="color: black; mso-fareast-font-family: µ¸¿ò; mso-no-proof: yes;"><font face="±¼¸²" size="3"></font></span></p>
Company
Terms of Use
Privacy Policy
Return Policy
Metaformula International, Corp.
Address: 12966 Euclid Street, Suite 210, Garden Grove, CA 92840
Contact:
help@metaformula.net
Copyright © 2018 Metaformula International, Corp. All rights reserved.